Market Size (2025)
$121.91M
Vertical: CNMBase Year: 2025
Market Size (2025)
$121.91M
Projected (2032)
$191.75M
CAGR (2022–2032)
6.7%
Key Players
10+
Market Overview
The Global Glyphosate Intermediates Market was valued at USD 121.91 Million in 2025 and is projected to reach USD 191.75 Million by 2032, registering a CAGR of 6.67% during 2026–2032. The market expanded from USD 100.03 Million in 2022 to USD 114.16 Million in 2024, and is expected to add USD 69.84 Million in absolute value between 2025 and 2032. The market covers the key chemical building blocks used to manufacture glyphosate technical, chiefly N-(phosphonomethyl)iminodiacetic acid (PMIDA) and glycine, together with other precursors such as iminodiacetic acid (IDA) and its salts, iminodiacetonitrile (IDAN) and dimethyl phosphite.
Demand for these intermediates is a direct function of glyphosate technical output, which in turn depends on the area planted to herbicide-tolerant soybean, corn and cotton, the spread of conservation tillage and no-till farming, and the use of glyphosate in plantation crops and non-crop vegetation management. Production is heavily concentrated in China, where integrated phosphorus chemical groups operate both the glycine route and the IDA route, while the leading Western producer relies on the IDA route through PMIDA. After the price peak of early 2022 and the oversupply-driven correction of 2023–2024, the industry has entered a phase in which capacity additions in China are restricted by industrial policy, environmental compliance costs are rising, and supply security has become a policy concern in the United States.
Key Findings
By Intermediate Type: PMIDA was the largest segment in 2025 with USD 67.05 Million (55.00% share) and is also the fastest-growing segment, with a CAGR of 7.33% during 2026–2032. Glycine & Others accounted for USD 54.86 Million (45.00%) and is projected to grow at a CAGR of 5.83%.
By Production Route: The IDA Route held the larger share in 2025 at USD 67.05 Million (55.00%) and is the fastest-growing route, with a CAGR of 7.10%. The Glycine Route accounted for USD 54.86 Million (45.00%) and is projected to grow at 6.12%.
Leading region: Asia Pacific dominated the market with USD 99.97 Million in 2025, equal to 82.00% of global value, and is projected to reach USD 158.27 Million by 2032 at a CAGR of 6.75%.
Fastest-growing region: Middle East & Africa is projected to record the highest regional CAGR of 9.45%, rising from USD 1.219 Million in 2025 to USD 2.282 Million by 2032.
Leading country: China was the largest country market at USD 72.18 Million in 2025 (59.20% of the global market) and is projected to reach USD 109.43 Million by 2032 at a CAGR of 6.08%.
Fastest-growing country: Saudi Arabia is projected to register the highest country-level CAGR of 10.38%, growing from USD 0.244 Million in 2025 to USD 0.484 Million by 2032. Among the larger markets, India stands out with a CAGR of 9.94%, increasing from USD 13.00 Million to USD 25.23 Million.
Segmentation Summary
The market is analysed by intermediate type (PMIDA; Glycine & Others), by production route (IDA Route; Glycine Route) and by region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa), with country-level detail within each region. Both product segmentations show the same balance in 2025, with PMIDA and the IDA Route each accounting for 55.00% of market value. Over the forecast period, PMIDA (7.33%) and the IDA Route (7.10%) are expected to outpace Glycine & Others (5.83%) and the Glycine Route (6.12%), reflecting planned PMIDA capacity additions in China, the IDA-based configuration of producers outside China, and the growing merchant trade in PMIDA as a transportable intermediate.
Competitive Landscape Summary
The supply side is concentrated among a limited number of integrated producers. Chinese companies such as Hubei Xingfa Chemicals Group, Sichuan Fuhua Tongda Agro-chemical, Zhejiang Xinan Chemical Industrial Group, Sichuan Hebang Biotechnology, Nantong Jiangshan Agrochemical & Chemicals, Jiangsu Yangnong Chemical and Anhui Guangxin Agrochemical account for the bulk of global glyphosate and intermediate capacity, while Bayer AG, whose US glyphosate business has operated as Ruveon LLC since July 2026, remains the principal integrated producer outside China. Competition is based on raw material integration (phosphate rock, yellow phosphorus, chlor-alkali and methanol), process efficiency, by-product recovery, and environmental compliance. Sichuan Hebang Biotechnology is positioned as the leading merchant supplier of PMIDA and is building additional PMIDA capacity in Guang'an, Sichuan.
Challenges and Opportunities
Key challenges include the cyclical and oversupplied nature of the glyphosate value chain, which kept Chinese glyphosate technical prices at low levels during 2023–2025, the high environmental burden of phosphorus-based effluents and glyphosate mother liquor, regulatory and litigation uncertainty around glyphosate in the United States and Europe, and use restrictions in markets such as India. Opportunities arise from the continued adoption of herbicide-tolerant crops in the Americas, the expansion of no-till farming, the need for geographically diversified supply highlighted by United States policy measures in 2026, and the shift towards cleaner, higher-yield PMIDA and glycine processes that reduce waste and raw material consumption.
Future Outlook
The market is expected to grow steadily, from USD 130.16 Million in 2026 to USD 191.75 Million in 2032. Asia Pacific will remain the production and consumption centre of the market, adding USD 58.30 Million between 2025 and 2032. Faster growth is projected in Middle East & Africa (9.45%) and Latin America (8.25%), albeit from smaller bases, while North America (5.41%) and Europe (5.11%) are projected to grow more slowly. The outcome of the US EPA's ongoing registration review, the implementation of the Roundup class settlement, China's restrictions on new glyphosate capacity, and the commissioning of new PMIDA capacity are the main factors that will shape the market through 2032.
The Glyphosate Intermediates Market market is projected to grow at a CAGR of 6.7% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Glyphosate (N-(phosphonomethyl)glycine) is a broad-spectrum, non-selective, post-emergence herbicide that inhibits the plant enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS). Glyphosate intermediates are the chemical compounds that are synthesised and either consumed captively or sold to other producers for the manufacture of glyphosate technical (typically 95% or higher purity). Two commercial production routes exist:
IDA Route: Iminodiacetic acid (IDA), produced from diethanolamine (DEA) by catalytic dehydrogenation or from hydrogen cyanide via iminodiacetonitrile (IDAN), is phosphonomethylated with phosphorous acid (or phosphorus trichloride) and formaldehyde to form PMIDA. PMIDA is then oxidised, typically with oxygen over a carbon or noble-metal catalyst or with hydrogen peroxide, to give glyphosate.
Glycine Route (alkyl ester route): Glycine reacts with paraformaldehyde and dimethyl phosphite in methanol in the presence of a tertiary amine catalyst such as triethylamine, followed by acid hydrolysis to yield glyphosate. Methyl chloride is generated as a by-product and is often recovered for use in silicone production.
Included in the scope: PMIDA (also known as glyphosine); glycine used for glyphosate synthesis; and other glyphosate-specific intermediates and precursors, including IDA and its sodium salts (such as DSIDA), IDAN and dimethyl phosphite, grouped under 'Glycine & Others'. Market value covers both merchant sales and the value of intermediates consumed captively by integrated glyphosate producers.
Excluded from the scope: glyphosate technical and glyphosate formulations (salts such as isopropylamine, potassium and ammonium glyphosate); glycine sold into food, feed, pharmaceutical and personal care applications; basic commodity inputs that are not specific to glyphosate, such as yellow phosphorus, phosphorus trichloride, methanol, formaldehyde, caustic soda and chlorine; and intermediates for other herbicides such as glufosinate.
Scope of the Study
Segmentation by Intermediate Type: PMIDA; Glycine & Others.
Segmentation by Production Route: IDA Route; Glycine Route.
Regions and countries: North America (U.S., Canada, Mexico); Europe (Germany, U.K., France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, Rest of Asia Pacific); Latin America (Brazil, Argentina, Rest of Latin America); Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA).
Timeline: Historic years 2022–2024; base year 2025; forecast period 2026–2032; CAGR period 2026–2032.
Currency and unit: Market values are presented in USD Million.
Research Objectives
To define, describe and quantify the global glyphosate intermediates market by intermediate type, production route and region for 2022–2032.
To estimate the market value of PMIDA and of Glycine & Others, and to assess the relative position of the IDA Route and the Glycine Route.
To analyse the drivers, restraints, opportunities, trends and challenges influencing intermediate demand, including herbicide-tolerant crop adoption and glyphosate pricing cycles.
To map the value chain from phosphate rock, yellow phosphorus and petrochemical inputs to glyphosate technical and end-use agriculture.
To assess the regulatory environment for glyphosate and its intermediates in the United States, the European Union, China, India and Latin America, and its implications for supply and demand.
To provide region- and country-level market estimates and growth outlooks for 20 country markets across five regions.
To identify and benchmark the leading producers of glyphosate intermediates and to track capacity expansions, restructuring and other strategic developments since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured research process consisting of (i) definition of the market scope and segmentation, (ii) extensive secondary research to build a fact base on glyphosate production capacity, process routes, trade flows, pricing and regulation, (iii) primary research with participants across the value chain to validate assumptions and fill data gaps, (iv) market size estimation using top-down and bottom-up approaches, (v) data triangulation, and (vi) forecasting based on demand, supply and regulatory factors. Findings were reviewed internally for consistency across segments, regions and countries before finalisation.
Secondary Research
Secondary research focused on sources relevant to the agrochemical and phosphorus chemical industries:
Industry associations: CropLife International and regional crop protection associations, the China Crop Protection Industry Association (CCPIA), and national pesticide manufacturer associations.
Government and regulatory bodies: the US Environmental Protection Agency (EPA), the European Food Safety Authority (EFSA) and the European Commission, China's Ministry of Ecology and Environment and Institute for the Control of Agrochemicals (ICAMA), India's Central Insecticides Board & Registration Committee (CIB&RC), USDA statistical services and the US Geological Survey.
Company filings: annual reports, interim results and exchange disclosures of listed producers on the Shanghai and Frankfurt exchanges, together with investor presentations and press releases.
Trade journals and industry media: agrochemical and chemical trade publications covering glyphosate pricing, capacity and plant operating rates.
Paid databases and trade statistics: customs and trade databases (including UN Comtrade and national customs statistics for organophosphorus compounds), and commercial chemical price reporting services.
Primary Research
Primary research was conducted through in-depth interviews and structured discussions with industry participants on both the supply and demand sides. Supply-side respondents included production, technical and commercial managers at producers of PMIDA, IDA, glycine and glyphosate technical, as well as raw material suppliers and traders of phosphorus chemicals. Demand-side respondents included glyphosate formulators, procurement managers at agrochemical companies, distributors, and agronomy specialists. The objectives were to validate capacity and operating-rate assumptions, understand the split between captive and merchant intermediates, confirm process-route economics, and gather views on pricing, regulation and demand outlook.
Market Size Estimation
Top-down approach: Global glyphosate technical output was estimated from capacity, operating rates and trade data. Intermediate requirements were derived using route-specific consumption ratios for PMIDA and glycine per tonne of glyphosate, and valued using average realised intermediate prices. The resulting market was allocated to regions and countries according to production and consumption patterns.
Bottom-up approach: Production volumes and values were estimated plant by plant and company by company for major producers, and aggregated by intermediate type, production route and country. Country-level consumption estimates were built from glyphosate use, formulation activity and trade data.
Data triangulation: The outputs of both approaches were compared and reconciled with secondary data and primary interview inputs. Differences were investigated and resolved to arrive at final estimates that are internally consistent across all segmentations and geographies.
Forecasting Methodology
Forecasts were developed by modelling the relationship between intermediate demand and glyphosate demand, and adjusting for structural changes in process routes and supply. The factors considered include planted area and herbicide-tolerant crop adoption, glyphosate application rates, conservation tillage trends, regulatory decisions and use restrictions, glyphosate and intermediate price trends, raw material costs (phosphorus, glycine, methanol and energy), announced capacity additions and closures, environmental compliance requirements, and trade policy. Each forecast year was assessed under base-case assumptions and reviewed for consistency with the historic trend.
Base Year, Forecast Period and Currency
Base year: 2025
Historic period: 2022–2024
Forecast period: 2026–2032
CAGR period: 2026–2032
Currency: USD Million
Assumptions and Limitations
Market values include both merchant sales and the value of intermediates consumed captively, valued at estimated market-equivalent prices.
Glyphosate remains approved in its major markets through the forecast period, including the European Union, where approval has been renewed until December 2033.
No major disruption to global trade in glyphosate and its intermediates, such as broad trade remedy duties, is assumed in the base case.
Values are expressed in nominal USD; exchange rate movements, in particular in the Chinese renminbi, may cause deviations from local-currency trends.
Company-level capacity and financial information is based on publicly available disclosures, which may differ in definition across companies and jurisdictions.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global glyphosate intermediates market is moderately consolidated. Production of PMIDA, IDA, IDAN and glycine for glyphosate is concentrated among a small number of integrated chemical groups, most of them located in China, together with Bayer AG, which operates the principal integrated IDA-route value chain outside China. A large share of intermediate output is consumed captively in the producers' own glyphosate plants, while a smaller merchant market exists for PMIDA, IDAN and glycine. Competition is driven primarily by cost position, which depends on access to phosphate rock and yellow phosphorus, integration with chlor-alkali, methanol and silicone production, catalyst and process efficiency, and the ability to treat or recycle by-products. Since February 2024, China's restriction on new glyphosate production units has shifted competition toward plant upgrades, backward integration, acquisitions of existing capacity and investment in merchant intermediates. Outside China, competitive dynamics are shaped by litigation, regulatory review and supply-security policy, as illustrated by the reorganisation of Bayer's US glyphosate business into Ruveon LLC in July 2026.
Key Player Positioning
Market Leaders
Bayer AG (Ruveon LLC): Bayer, headquartered in Leverkusen, Germany, reported group sales of EUR 45.575 billion and Crop Science sales of EUR 21.622 billion in fiscal 2025. Through the Monsanto legacy business it operates an integrated IDA-route chain in the United States, from elemental phosphorus at Soda Springs, Idaho, to IDA-route glyphosate production at Luling, Louisiana. Its US glyphosate business has operated as Ruveon LLC since July 2026. Strategy centres on ring-fencing glyphosate, securing raw materials and resolving litigation.
Hubei Xingfa Chemicals Group: A phosphorus chemicals group based in Yichang, Hubei, with reported revenue of about RMB 29.3 billion in 2025. It is integrated from phosphate rock and yellow phosphorus to glycine and glyphosate, with a reported glyphosate technical design capacity of 230,000 tonnes per year through Hubei Taisheng Chemical and Inner Mongolia Xingfa, using the glycine route. Its strategy combines cost leadership in glyphosate with investment in electronic chemicals and battery materials.
Sichuan Fuhua Tongda Agro-chemical (Fuhua Group): A privately controlled producer founded in 2007 in Leshan, Sichuan, with reported revenue of RMB 9.529 billion in 2022. It operates a reported 150,000 tonnes per year of glycine-route glyphosate capacity supported by captive mining and chlor-alkali assets.
Sichuan Hebang Biotechnology: Based in Leshan, Sichuan, with reported revenue of RMB 7.188 billion in 2025. It is the leading IDA-route producer in China and a major merchant supplier of PMIDA, with reported capacity of 200,000 tonnes per year of PMIDA and 60,000 tonnes per year of glyphosate. It is building a large PMIDA project in Guang'an, Sichuan, and a glyphosate project in Indonesia.
Challengers
Zhejiang Xinan Chemical Industrial Group (Wynca): Based in Jiande, Zhejiang, with reported revenue of RMB 14.625 billion in 2025. It operates a reported 80,000 tonnes per year of glyphosate capacity integrated with organosilicon production through methyl chloride recovery.
Nantong Jiangshan Agrochemical & Chemicals: Based in Nantong, Jiangsu, with reported revenue of RMB 5.816 billion in 2025. It operates both the glycine route and the IDAN-based IDA route, allowing it to shift output according to raw material prices, and has expanded into Guizhou with yellow phosphorus and glyphosate capacity.
Jiangsu Yangnong Chemical: An affiliate of Sinochem Holdings and Syngenta Group with reported revenue of RMB 11.87 billion in 2025, and a reported glyphosate capacity of 40,000 tonnes per year within a broader agrochemical portfolio.
Anhui Guangxin Agrochemical: Reported revenue of RMB 3.532 billion in 2025 and a reported 60,000 tonnes per year of glycine-route glyphosate capacity, alongside its phosgene-based chemistry business.
Jiangsu Good Harvest-Weien Agrochemical: A Jiangsu-based producer with a reported 70,000 tonnes per year of glyphosate capacity.
Niche Players
Henan Hongdongfang Chemical: A glycine-route glyphosate producer with a reported capacity of 30,000 tonnes per year.
Chongqing Unisplendour Chemical: A producer of IDAN, an upstream intermediate for IDA and PMIDA, serving IDA-route glyphosate producers.
Competitor Dashboard
The dashboard below rates each profiled company on four parameters relevant to the glyphosate intermediates market, based on publicly available information on product range, geographic reach, partnerships and operating history.
Threat of New Entrants: Low
High capital requirements for integrated phosphorus, intermediate and effluent treatment facilities.
China's classification of glyphosate production as a restricted category limits new capacity.
Established producers benefit from scale, proprietary catalysts and process know-how.
Bargaining Power of Suppliers: Medium
Yellow phosphorus supply is concentrated in regions with phosphate rock and low-cost power, and is affected by energy and environmental policies.
Leading producers mitigate supplier power through backward integration into phosphate rock and phosphorus.
Commodity inputs such as methanol, caustic soda and ammonia are widely available from multiple suppliers.
Bargaining Power of Buyers: Medium
Large agrochemical companies and formulators purchase significant volumes and can switch between suppliers.
Buyer power rises during periods of oversupply, as seen in 2023–2024.
Integrated producers consume most intermediates captively, limiting the share of the market exposed to external buyers.
Threat of Substitutes: Low
There is no commercial alternative to PMIDA or glycine for producing glyphosate.
Competing herbicides such as glufosinate, dicamba and 2,4-D are used alongside glyphosate rather than replacing it at scale.
Non-chemical weed control methods remain limited to niche applications.
Intensity of Competitive Rivalry: High
A small number of large Chinese producers compete intensely on cost and price, particularly in export markets.
Price cycles lead to aggressive pricing when operating rates fall.
Producers differentiate through integration, process efficiency and environmental compliance rather than product features.
Threat of New Entrants: Low; Capital intensity, capacity restrictions in China, process know-how.
Bargaining Power of Suppliers: Medium; Concentrated phosphorus supply, offset by backward integration.
Bargaining Power of Buyers: Medium; Large formulators, cyclical oversupply, high captive consumption.
Threat of Substitutes: Low; No alternative route inputs; competing herbicides are complementary.
Competitive Rivalry: High; Concentrated, cost-driven competition among integrated producers.
Market estimates by geography (2032)
InsightAsia Pacific leads with $158.27M by 2032, while Middle East & Africa is projected to grow fastest at a 9.2% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $10.41M | $13.55M | $17.62M | 5.4% | 9% |
| Europe | $3.16M | $4.03M | $5.18M | 5.1% | 3% |
| Asia Pacific | $81.45M | $114.31M | $158.27M | 6.9% | 83% |
| Latin America | $4.05M | $5.61M | $8.40M | 7.6% | 4% |
| Middle East & Africa | $0.95M | $1.45M | $2.28M | 9.2% | 1% |
| Total | $100.03M | $138.95M | $191.75M | 6.7% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$191.75M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| PMIDA | $110.04M | 7.3% | 57% |
| Glycine & Others | $81.70M | 5.9% | 43% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Glyphosate Intermediates Market covering market dynamics, competitive landscape, and strategic outlook.
The Glyphosate Intermediates Market market is projected to reach $191.75M by 2032, growing at 6.7% CAGR. The PMIDA segment holds the largest share.
The glyphosate intermediates market is shaped by the demand for glyphosate in row-crop agriculture, the structure of the phosphorus chemical industry, and the regulatory treatment of glyphosate in key consuming countries. Because PMIDA and glycine have limited outlets beyond glyphosate synthesis, their demand closely follows glyphosate technical production, while their profitability depends on raw material costs, process efficiency and the glyphosate price cycle. This chapter assesses the factors promoting and inhibiting market growth. The impact scores presented in the growth factor analysis are analyst assessments based on secondary research and industry discussions, expressed on a scale of 1 (low impact) to 10 (high impact) for three forecast sub-periods.
Widespread Adoption of Herbicide-Tolerant Crops
Herbicide-tolerant varieties of soybean, corn and cotton remain the single most important source of glyphosate demand and, therefore, of demand for PMIDA and glycine. In the United States, USDA data show that herbicide-tolerant varieties account for more than 90% of soybean, corn and cotton plantings. In Brazil, genetically engineered varieties account for about 99% of soybean and cotton area and 96% of corn area, according to the USDA Foreign Agricultural Service, with total biotech crop area forecast at 69.6 million hectares in 2024/25. Argentina continues to approve new biotech events, including stacked herbicide-tolerance traits. These systems depend on post-emergence glyphosate applications, often in combination with other modes of action to manage resistant weeds. As long as glyphosate remains the anchor herbicide in these systems, steady growth in planted area in the Americas supports base-load demand for glyphosate technical and its intermediates, and underpins export demand from Chinese producers, which export a large share of their glyphosate output, with South America as a principal destination.
Growth of Conservation Tillage and No-Till Agriculture
No-till and reduced-tillage systems use burndown herbicides instead of mechanical cultivation to control weeds before planting. Glyphosate is the most widely used burndown product because of its broad spectrum, low cost and lack of soil residual activity. Conservation agriculture is well established in Brazil, Argentina, the United States, Canada and Australia, and is being promoted in parts of Asia and Africa to reduce soil erosion, conserve moisture and lower fuel and labour costs. Policies that reward soil carbon sequestration and regenerative practices further encourage the adoption of no-till systems. Each hectare converted to no-till typically adds at least one burndown application per season, which translates into incremental demand for glyphosate and, upstream, for PMIDA and glycine. In Brazil and Argentina, no-till is practised on a large share of grain area, and the expansion of second-crop corn after soybean adds further burndown applications. This driver is particularly relevant for the faster-growing markets of Latin America and the Middle East & Africa.
Investment in PMIDA Capacity and Process Upgrades in China
Chinese producers are investing in PMIDA and upstream intermediate capacity to secure feedstock and serve export customers. In April 2022, Sichuan Hebang Biotechnology announced a project for 500,000 tonnes per year of PMIDA in Guang'an, Sichuan, with planned investment of RMB 12.5 billion; as of mid-2026 the project was reported to be scheduled for completion in October 2027. The company's existing reported PMIDA capacity of 200,000 tonnes per year already makes it a major merchant supplier to glyphosate producers. Since February 2024, China's Industrial Structure Adjustment Guidance Catalogue has classified glyphosate production units as a restricted category, which limits new glyphosate lines and encourages producers to upgrade existing plants and integrate backwards into intermediates and raw materials. Nantong Jiangshan Agrochemical & Chemicals, for example, commissioned a yellow phosphorus plant in Guizhou in December 2025 alongside a new glyphosate base. These investments expand the supply of tradable PMIDA, support the higher growth of the PMIDA and IDA Route segments, and strengthen China's position as the global supply hub for glyphosate intermediates.
Supply-Security Priorities in Major Consuming Countries
Glyphosate has been recognised as a strategic input for agriculture. In February 2026, the United States issued an executive order under the Defense Production Act prioritising the domestic production of elemental phosphorus and glyphosate-based herbicides. In October 2025, the US Bureau of Land Management approved the Caldwell Canyon phosphate mine in Idaho, which is to supply phosphate ore to the Soda Springs elemental phosphorus plant serving Bayer's glyphosate production. In July 2026, Bayer consolidated its US glyphosate business into Ruveon LLC, a dedicated entity for continued domestic production, and the June 2026 Supreme Court decision in Monsanto Co. v. Durnell reduced the legal risk associated with that production. Such measures sustain intermediate production outside China, where the IDA Route through PMIDA is the dominant technology. At the same time, the dependence of many importing countries on Chinese supply is encouraging formulators in India, Latin America and the Middle East to consider local glyphosate technical synthesis from imported PMIDA, which would raise merchant demand for this intermediate.
Merchant PMIDA Supply to New Glyphosate Producers
PMIDA is a stable, transportable solid that can be oxidised to glyphosate in relatively compact plants. This creates an opportunity for intermediate producers to supply PMIDA to glyphosate producers in countries seeking local technical manufacturing, including India, Southeast Asia and Latin America. Sichuan Hebang Biotechnology is building a 350,000 tonnes per year glyphosate project in Indonesia, illustrating the shift towards distributed glyphosate synthesis supplied with Chinese intermediates.
Growth in Emerging Agricultural Markets
Latin America and the Middle East & Africa are projected to record the highest regional growth rates in this market. Expanding soybean and corn area in Brazil and Argentina, rising mechanisation and plantation agriculture in Africa, and the promotion of conservation agriculture create incremental demand for glyphosate. Countries such as Saudi Arabia and the UAE, which invest in food security and controlled agriculture, are also building agrochemical distribution and formulation capabilities.
Cleaner and More Efficient Process Technologies
Process improvements offer producers the opportunity to reduce cost and environmental impact. Examples include catalytic oxidation of PMIDA with oxygen, recovery of methyl chloride, methanol and triethylamine in the glycine route, recycling of phosphorus from mother liquor, and integration of glyphosate with silicone and chlor-alkali production. Producers that adopt these technologies can operate profitably through price cycles and comply with tightening effluent standards, gaining share from less efficient competitors.
Regulatory Scrutiny and Litigation Surrounding Glyphosate
Glyphosate remains subject to regulatory and legal scrutiny. In the United States, the Ninth Circuit vacated the human-health portion of the EPA's 2020 interim registration review decision in June 2022, and the EPA withdrew the interim decision in September 2022; an updated human-health assessment is anticipated in late 2026. Bayer has faced extensive Roundup litigation, proposed a class settlement of up to USD 7.25 billion in February 2026, and stated during 2025 that it might stop producing glyphosate without legal relief. India restricted glyphosate use to pest control operators through the Restriction on Use of Glyphosate Order, 2022. Such measures create uncertainty for long-term investment in intermediates and can reduce glyphosate use in specific markets.
Oversupply and Price Volatility in the Glyphosate Value Chain
The glyphosate value chain is prone to sharp price cycles. Chinese glyphosate technical prices peaked at around RMB 78,500 per tonne in early 2022, then fell to around RMB 24,300 per tonne by mid-2023 and remained mostly between RMB 23,000 and RMB 27,000 per tonne through 2024 and the first half of 2025, as industry capacity exceeded demand. Low prices compress margins for intermediate producers, delay investment and lead to the idling of less efficient capacity. Because intermediates are priced with reference to glyphosate, these cycles translate directly into volatility in intermediate market value.
Environmental Burden of Intermediate Production
Both routes generate significant waste streams. The glycine route produces glyphosate mother liquor containing phosphorus compounds and salts, while the IDA route produces saline effluents and requires careful handling of formaldehyde and, where IDAN is used, hydrogen cyanide. China has required environmental verification of glyphosate and PMIDA producers since 2013, and the GB 21523-2024 pesticide industry water pollutant discharge standard tightens wastewater requirements, with a December 2026 deadline for existing pesticide technical plants that discharge indirectly. Compliance raises capital and operating costs and can force the closure of smaller, non-integrated plants.
Backward Integration into Phosphorus and Raw Materials
Leading producers are integrating from phosphate rock through yellow phosphorus to intermediates and glyphosate. Hubei Xingfa Chemicals Group operates a chain from phosphate rock to glyphosate, Nantong Jiangshan has added yellow phosphorus capacity in Guizhou, and Bayer has secured a new phosphate ore source for its Soda Springs plant. Integration lowers cost volatility and raises barriers to entry.
Consolidation and Capacity Discipline in China
With new glyphosate capacity restricted under China's industrial policy and the government's broader campaign against excessive price competition, the industry is consolidating around large integrated producers. Capacity growth is achieved mainly through upgrades and acquisitions of existing licences, which supports more stable operating rates and pricing for intermediates.
Restructuring of Western Glyphosate Supply
In July 2026, Bayer consolidated its US glyphosate business into a distinct entity operating as Ruveon LLC. Ruveon filed anti-dumping and countervailing duty petitions against Chinese glyphosate in mid-2026 and withdrew them shortly afterwards following opposition from farm groups. These developments indicate continuing debate over the balance between domestic production and access to competitively priced imports.
Challenge of Weed Resistance
The spread of glyphosate-resistant weeds such as Palmer amaranth, waterhemp and kochia has led growers to add other herbicide modes of action and to adopt crops tolerant to dicamba, 2,4-D and glufosinate. While glyphosate usually remains part of these programmes, resistance management may limit growth in application rates per hectare in mature markets.
The value chain of the glyphosate intermediates market extends from basic mineral and petrochemical inputs to the farmers and vegetation managers who apply glyphosate. The main stages are described below.
Raw materials and inputs: Phosphate rock is converted into yellow (elemental) phosphorus, which is used to make phosphorus trichloride, phosphorous acid and dimethyl phosphite. Other inputs include methanol and formaldehyde, diethanolamine or hydrogen cyanide (for IDA and IDAN), chloroacetic acid and ammonia (for glycine), triethylamine, hydrochloric acid, caustic soda, and energy. Access to low-cost phosphorus and chlor-alkali products is a key determinant of competitiveness.
Intermediate manufacturing: Producers synthesise IDA or IDAN and convert it to PMIDA, or produce glycine and dimethyl phosphite for the alkyl ester route. Intermediates are either consumed captively in integrated glyphosate plants or sold to other glyphosate producers. This stage requires catalyst technology, effluent treatment and by-product recovery.
Glyphosate technical synthesis: PMIDA is oxidised to glyphosate, or glycine is reacted with paraformaldehyde and dimethyl phosphite and hydrolysed, to produce glyphosate technical of 95% or higher purity.
Formulation, distribution and channels: Glyphosate technical is converted into salt-based formulations (isopropylamine, potassium and ammonium salts) by agrochemical companies and formulators, and sold through national distributors, agricultural cooperatives and retail dealers. A large share of Chinese technical and formulation output is exported.
End users: Farmers growing soybean, corn, cotton, canola, cereals and plantation crops (oil palm, rubber, fruit orchards), as well as non-crop users such as railway, road and utility vegetation managers and forestry operators.
North America
United States: Glyphosate products are registered under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). The EPA's registration review is ongoing after the 2020 interim decision was withdrawn in 2022. In June 2026, the US Supreme Court held in Monsanto Co. v. Durnell that FIFRA preempts state-law failure-to-warn claims seeking a cancer warning. A February 2026 executive order under the Defense Production Act prioritises domestic elemental phosphorus and glyphosate-based herbicide production.
Canada: Pesticides are regulated by Health Canada's Pest Management Regulatory Agency (PMRA) under the Pest Control Products Act; glyphosate's registration was renewed following re-evaluation in 2017.
Europe
Active substances are approved under Regulation (EC) No 1107/2009. Commission Implementing Regulation (EU) 2023/2660 renewed the approval of glyphosate until 15 December 2033, with conditions including a prohibition on use as a pre-harvest desiccant.
Chemical intermediates manufactured in or imported into the EU are subject to REACH (Regulation (EC) No 1907/2006), and maximum residue levels are set under Regulation (EC) No 396/2005.
Asia Pacific
China: Pesticide manufacturing and registration are governed by the Regulations on Pesticide Administration, with registration managed by ICAMA under the Ministry of Agriculture and Rural Affairs. The Industrial Structure Adjustment Guidance Catalogue (2024 edition) lists glyphosate production units as restricted. GB 21523-2024 sets water pollutant discharge standards for the pesticide industry.
India: Pesticides are regulated under the Insecticides Act, 1968 through the CIB&RC. The Restriction on Use of Glyphosate Order, 2022 (S.O. 5010(E)) limits glyphosate application to pest control operators.
Australia: The Australian Pesticides and Veterinary Medicines Authority (APVMA) regulates glyphosate products under the Agricultural and Veterinary Chemicals Code.
Latin America
Brazil: Law No. 14,785/2023 established a new framework for pesticide registration, with the Ministry of Agriculture and Livestock (MAPA) as the lead authority, supported by ANVISA and IBAMA for health and environmental assessments. ANVISA's toxicological re-evaluation of glyphosate resulted in additional use restrictions.
Argentina: Plant protection products are registered by the National Agri-Food Health and Quality Service (SENASA).
Middle East & Africa
Pesticide registration in Saudi Arabia is administered by the Ministry of Environment, Water and Agriculture, and in South Africa under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).
Apr 2022: Sichuan Hebang Biotechnology; Expansion; Announced a 500,000 tonnes per year PMIDA project in Guang'an, Sichuan, with planned investment of RMB 12.5 billion.
Jun 2023: Nantong Jiangshan Agrochemical & Chemicals; Expansion; Established Guizhou Jiangshan Crop Science (65% owned) in Weng'an, Guizhou, as a new glyphosate production base.
Apr 2025: Bayer AG; Strategy; Stated that it could stop producing glyphosate unless it obtained relief from product liability litigation.
Oct 2025: Bayer AG (P4 Production LLC); Expansion; Received US Bureau of Land Management approval for the Caldwell Canyon phosphate mine, which will supply the Soda Springs elemental phosphorus plant.
Dec 2025: Nantong Jiangshan Agrochemical & Chemicals; Expansion; Started up a 66,000 tonnes per year yellow phosphorus plant in Guizhou and completed Phase I (50,000 tonnes per year) of its Guizhou glyphosate project.
Feb 2026: Bayer AG (Monsanto); Legal Settlement; Announced a proposed Roundup class settlement of up to USD 7.25 billion to resolve current and future claims.
Apr 2026: Sichuan Hebang Biotechnology; Investment; Announced a 600,000 tonnes per year methionine project with planned investment of RMB 7.747 billion, diversifying beyond PMIDA and glyphosate.
Jun 2026: Bayer AG (Monsanto); Legal; The US Supreme Court ruled in Monsanto Co. v. Durnell that FIFRA preempts state-law failure-to-warn claims seeking a cancer warning.
Jul 2026: Bayer AG; Restructuring; Consolidated its US glyphosate business into a distinct entity operating as Ruveon LLC, headquartered in St. Louis.
Jul 2026: Ruveon LLC; Trade; Filed anti-dumping and countervailing duty petitions against glyphosate imports from China, and withdrew them in mid-July 2026.
Jul 2026: Sichuan Hebang Biotechnology; Expansion; Reported its Guang'an PMIDA project as scheduled for completion in October 2027, and its 350,000 tonnes per year glyphosate project in Indonesia as under construction.
Political
Industrial policy in China restricts new glyphosate capacity and influences export supply.
Supply-security measures in the United States, including the 2026 Defense Production Act order, support domestic phosphorus and glyphosate production.
Trade remedy actions, such as the 2026 US anti-dumping petition that was later withdrawn, can alter trade flows.
Economic
Glyphosate and intermediate prices follow pronounced cycles driven by capacity utilisation and inventory.
Farm income and crop prices influence herbicide purchasing decisions in the Americas.
Energy and phosphorus costs account for a large share of intermediate production costs.
Social
Public concern about glyphosate safety, amplified by litigation in the United States, affects consumer and policymaker perception.
Labour shortages and rising wages in agriculture favour herbicide-based weed control over manual weeding.
Technological
Advances in PMIDA oxidation catalysts and by-product recovery improve yields and reduce waste.
New herbicide-tolerant crop traits and stacked traits sustain glyphosate use in combination programmes.
Precision application technologies may reduce application rates per hectare over time.
Environmental
Effluent and solid waste from phosphorus-based chemistry are subject to tightening discharge standards.
Conservation tillage, which relies on glyphosate burndown, is promoted for soil and carbon benefits.
Weed resistance encourages diversified weed control strategies.
Legal
Registration review in the United States and renewal conditions in the European Union define the scope of permitted uses.
Product liability litigation and settlements affect the strategy of Western producers.
National use restrictions, such as India's 2022 order, limit specific end uses.
Profiles of 106 companies operating in the Glyphosate Intermediates Market market, including revenue, employee count, and market positioning where available.
Showing 106 of 106 companies
Bayer is a German life-science group with three businesses: Crop Science, Pharmaceuticals and Consumer Health. It is the world's largest combined seed, trait and crop-protection supplier, a mid-sized prescription-drug maker, and a top-five self-care company. Fiscal 2025 sales were EUR 45.6 billion. The 2018 purchase of Monsanto brought leading corn and soybean genetics but also glyphosate and PCB litigation, which has consumed well over EUR 10 billion in settlements and produced net losses in 2023, 2024 and 2025. Under CEO Bill Anderson the company has cut management layers, held the dividend at the legal minimum, and concentrated on four priorities: rebuilding the pharma pipeline, containing litigation, reducing debt and improving crop profitability. In 2026 a 7–2 U.S. Supreme Court ruling on federal pre-emption and a proposed USD 7.25 billion class settlement moved the litigation closer to resolution, though the settlement still awaits final court approval. --- **Company's own description.** Bayer describes itself as a global enterprise with core competencies in the life-science fields of health care and nutrition, operating under the mission "Health for all, Hunger for none" (Annual Report 2025; press boilerplate 2026). Bayer AG is a holding company; operations sit in subsidiaries worldwide. In fiscal 2025 the Group had about 88,000 employees, sales of EUR 45.6 billion and R&D expenses of EUR 5.8 billion. **Independent characterisation.** Bayer is best understood as three distinct businesses sharing a balance sheet, a brand and a legal liability. Crop Science (47 percent of FY2025 sales) is an input supplier to farmers. It earns money from proprietary seed and biotech traits, from chemical and biological crop protection, and to a small extent from digital farming subscriptions. Seed and trait revenue carries royalty-like economics: Bayer licenses traits to other seed companies, and two licensing settlements with Corteva lifted results in Q4 2025 and Q1 2026. The business is strongly seasonal, with Northern Hemisphere sales concentrated in the first half and Latin American sales in the second. Pharmaceuticals (39 percent of sales) discovers, develops and sells prescription medicines, concentrated in cardiovascular and renal disease, oncology, women's health and ophthalmology, plus a radiology unit selling contrast agents and injector hardware. Revenue is almost entirely product sales, with some licence income (for example U.S. Xarelto royalties from Johnson & Johnson, and Eylea outside the United States under a collaboration with Regeneron). The division is in the middle of a patent transition: Xarelto and Eylea are declining while Nubeqa and Kerendia are growing quickly. Consumer Health (13 percent of sales) sells non-prescription brands through pharmacies, mass retail and e-commerce. It is a branded consumer-goods model with stable margins and low capital intensity. **Revenue model mix.** Bayer does not disclose a product/service/licensing split. On the evidence of the Annual Report 2025, the large majority of revenue is product sales; licensing income is embedded in Crop Science seed and trait lines and in Pharmaceuticals; subscription revenue (Climate FieldView, radiology software) is immaterial at Group level. An exact percentage split is not publicly disclosed. **Value-chain position.** Bayer is a research-based originator and manufacturer. It owns discovery, development, active-ingredient and finished-product manufacturing, and commercial organisations, and sells through distributors, retailers, wholesalers, hospitals and pharmacies rather than directly to end users in most markets. **Customers and end markets.** Farmers, agricultural retailers and distributors, and seed licensees (Crop Science); wholesalers, hospitals, physicians, pharmacy chains, governments and payers (Pharmaceuticals); pharmacies, supermarkets, drugstores and online retailers (Consumer Health).
3 interactive charts drawn from the Glyphosate Intermediates Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Glyphosate Intermediates Market By Production Route
Global Glyphosate Intermediates Market By Intermediate Type
Global Glyphosate Intermediates Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)